PMID- 21560252 OWN - NLM STAT- MEDLINE DCOM- 20111013 LR - 20110815 IS - 1934-6638 (Electronic) IS - 1934-662X (Linking) VI - 119 IP - 4 DP - 2011 Aug 25 TI - Cytopathology of "double-hit" non-Hodgkin lymphoma. PG - 263-71 LID - 10.1002/cncy.20160 [doi] AB - BACKGROUND: B-cell lymphomas with concurrent IGH-BCL2 and c-MYC rearrangements (so-called "double-hit lymphomas" [DHL]) are a relatively rare, recently described category in the 2008 World Health Organization classification of hematopoietic neoplasms. Response to chemotherapy and survival are poor. METHODS: The authors reviewed files of cytogenetically documented DHL to identify cytologic features that would allow its possible recognition. RESULTS: Twelve fine-needle aspirates (FNAs), 2 pleural fluids, and 1 touch imprint of cytogenetically proven DHL were uncovered. Primary DHL was correctly recognized in 3 of 12 FNA cases using Ki-67 staining coupled with a positive bcl-2 result as the basis for performing fluorescence in situ hybridization (FISH) analysis of c-MYC and IGH-BCL2 rearrangements. Remaining FNAs and non-FNA cases were diagnosed as non-Hodgkin lymphoma, B-cell lymphoma, or atypical lymphocytosis. Ten cases had cell block material available. All cases had high cellularity with a dissociated smear pattern and background lymphoglandular bodies. Cell size ranged from intermediate to large. Nuclei were predominantly rounded or slightly irregular in contour; 4 FNAs had markedly cleaved nuclei. Some nuclei harbored discrete but small nucleoli, whereas in others coarse chromatin and indistinct or multiple small nucleoli existed. A variable number of mitotic figures, tingible body macrophages, and background apoptotic cells were also present. CONCLUSIONS: No specific cytomorphologic feature(s) were found to reliably identify DHL using FNA or exfoliative cytology. A high Ki-67 proliferation index and positive bcl-2 staining (on cytospin slides or cell block material) of cases not conforming to typical Burkitt lymphoma morphology should prompt FISH analysis for c-MYC and/or IGH-BCL2 rearrangements to identify DHL, particularly if tissue biopsy is not expected. CI - Copyright (c) 2011 American Cancer Society. FAU - Elkins, Camille T AU - Elkins CT AD - Department of Pathology, The Ohio State University College of Medicine, Columbus, USA. FAU - Wakely, Paul E Jr AU - Wakely PE Jr LA - eng PT - Journal Article DEP - 20110510 PL - United States TA - Cancer Cytopathol JT - Cancer cytopathology JID - 101499453 RN - 0 (Immunoglobulin Heavy Chains) RN - 0 (Ki-67 Antigen) RN - 0 (MYC protein, human) RN - 0 (Oncogene Proteins, Fusion) RN - 0 (Proto-Oncogene Proteins c-bcl-2) RN - 0 (Proto-Oncogene Proteins c-myc) SB - IM MH - Adult MH - Aged MH - Aged, 80 and over MH - Biopsy, Fine-Needle MH - Female MH - Follow-Up Studies MH - *Gene Rearrangement MH - Humans MH - Immunoglobulin Heavy Chains/genetics MH - In Situ Hybridization, Fluorescence MH - Karyotyping MH - Ki-67 Antigen MH - Lymphoma, Non-Hodgkin/*genetics/*pathology MH - Male MH - Middle Aged MH - Oncogene Proteins, Fusion/*genetics MH - Prognosis MH - Proto-Oncogene Proteins c-bcl-2/genetics MH - Proto-Oncogene Proteins c-myc/genetics MH - *Translocation, Genetic EDAT- 2011/05/12 06:00 MHDA- 2011/10/14 06:00 CRDT- 2011/05/12 06:00 PHST- 2011/02/23 00:00 [received] PHST- 2011/03/26 00:00 [revised] PHST- 2011/03/28 00:00 [accepted] PHST- 2011/05/12 06:00 [entrez] PHST- 2011/05/12 06:00 [pubmed] PHST- 2011/10/14 06:00 [medline] AID - 10.1002/cncy.20160 [doi] PST - ppublish SO - Cancer Cytopathol. 2011 Aug 25;119(4):263-71. doi: 10.1002/cncy.20160. Epub 2011 May 10.